VIM and endometrial cancer: More in details, P4 modulates TGF-β signaling in endometrial cancer cells at ligands, receptors, and Smads levels, thus inhibiting invasiveness as a consequence of an increase in E-cadherin and a decrease in Vimentin expression41.